Papillophlebitis associated with the use of oral contraceptive: a case report.
We present a 20-year-old female patient with papillophlebitis in the right eye. Minimal expansion of the blind spot and nasal peripheral defects in the right eye visual field were detected. The patient was using ethinyl estradiol-cyproterone acetate for ovarian cyst and menstrual irregularity. An improvement in the patient's visual field began within a week after cessation of ethinyl estradiol-cyproterone acetate. Ophthalmoscopic findings resolved completely in the sixth week. This situation suggests that female sex hormones or thromboembolic process caused by them may be responsible for the pathogenesis of papillophlebitis. But the exact mechanism in the pathogenesis of papillophlebitis is still controversial.
a Department of Ophthalmology and.
Ozlem
O
Eski Yücel
a Department of Ophthalmology and.
Inci
I
Güngor
a Department of Ophthalmology and.
Adem
A
Gül
b Department of Internal Medicine, Division of Hematology, Medical Faculty , Ondokuz Mayis University , Samsun , Turkey.
Mehmet
M
Turgut
a Department of Ophthalmology and.
Nursen
N
Aritürk
D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects* / Q000627:therapeutic use; D017373:Cyproterone Acetate / Q000009:adverse effects* / Q000627:therapeutic use; D004338:Drug Combinations; D004997:Ethinyl Estradiol / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008599:Menstruation Disturbances / Q000188:drug therapy; D010048:Ovarian Cysts / Q000188:drug therapy; D010211:Papilledema / Q000139:chemically induced*; D055815:Young Adult
D003278:Contraceptives, Oral, Hormonal; D004338:Drug Combinations; D004997:Ethinyl Estradiol; D017373:Cyproterone Acetate; C032640:Cyproterone acetate, ethinyl estradiol drug combination
Big blind spot syndrome; ethinyl estradiol-cyproterone acetate; female sex hormone; papillophlebitis